Marvel Biosciences Corp (TSE:MRVL) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Marvel Biosciences Corp. is excited to announce an upcoming private placement aiming to raise $1 million by offering 10 million units at $0.10 each, which include a share and a purchase warrant. The funds raised will be allocated to further pre-clinical trials on treatments for chronic Alzheimer’s and Autism, as well as general corporate purposes. This investment opportunity is available to accredited investors and is subject to a four-month hold period in Canada.
For further insights into TSE:MRVL stock, check out TipRanks’ Stock Analysis page.